20022159

Chen X

2010

Increased plasma metastin levels in adolescent women with polycystic ovary syndrome.

20022229

Mohamadin AM

2010

Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome.

20022685

Swanton A

2010

IVF outcome in women with PCOS, PCO and normal ovarian morphology.

20023292

Carlsen SM

2010

Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.

20029224

Nawaz FH

2010

Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.

20031018

Lainas TG

2009

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase.

20032061

Yang JL

2010

Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis.

20032951

Zhidkova IA

2009

[Reproductive potential of women with epilepsy].

20033367

Kajihara T

2009

Increased ovarian follicle atresia in obese Zucker rats is associated with enhanced expression of the forkhead transcription factor FOXO1.

20034411

Filali M

2009

Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency.

20036327

Baptiste CG

2010

Insulin and hyperandrogenism in women with polycystic ovary syndrome.

20039595

Alsantali A

2009

Management of hirsutism.

20041287

Xu P

2010

Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome.

20041792

Kim SH

2009

HemoHIM improves ovarian morphology and decreases expression of nerve growth factor in rats with steroid-induced polycystic ovaries.

20042102

Ott J

2009

Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study.

20045799

Xita N

2009

The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome.

20046314

Dean HJ

2002

Type 2 diabetes, polycystic ovary syndrome and the insulin resistance syndrome in adolescents: Are they one big iceberg?

20047740

Herbert DL

2010

Depression: an emotional obstacle to seeking medical advice for infertility.

20050299

Homburg R

2010

Reply: A new method for testing a hypothesis on a cause of polycystic ovary syndrome.

20050767

Moran L

2010

Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options.

20051691

Chattopadhayay R

2010

Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome.

20054201

Vrbikova J

2009

Obesity and polycystic ovary syndrome.

20056308

Altieri P

2010

Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes.

20057162

Wu XY

2010

Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.

20059655

Battaglia C

2010

PCOS and urethrovaginal space: 3-D volumetric and vascular analysis.

20060112

Hart R

2010

Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS).

20060523

Georgopoulos NA

2010

Serum AMH, FSH, and LH levels in PCOS.

20060957

Dewailly D

2010

Androgen excess in women: not just a cosmetic problem.

20067121

Li Y

2009

[The activity of platelet activating factor acetylhydrolase and its metabolic profile in patients with polycystic ovary syndrome].

20067879

Jakimiuk AJ

2009

PCOS and cancer risk.

20067969

Karakas SE

2010

Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome.

20067985

Wong DH

2010

Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells.

20069140

De Leo V

2009

Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.

20070410

Padmanabhan V

2010

Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators.

20074021

Ercan CM

2010

Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.

20074022

Usnarska-Zubkiewicz L

2010

Pregnancy in a woman with polycystic ovary syndrome and myelodysplastic syndrome (in the form of refractory anemia) treated with allogeneic hemopoietic stem-cell transplantation (alloHSCT).

20078960

Chen XL

2009

[Plasma metastin in adolescent polycystic ovary syndrome.].

20079483

Duranteau L

2010

Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?

20079899

Kazerooni T

2010

Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.

20080859

O'Connor A

2010

High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.

20080874

Garside SA

2010

Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.

20082945

Katsambas AD

2010

Hormonal therapy for acne: why not as first line therapy? facts and controversies.

20088734

Pandey S

2010

Impact of obesity on gynecology.

20089208

Trolle D

2010

[Polycystic ovary syndrome: across the specialties].

20089209

Glintborg D

2010

[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome].

20089210

Haugaard LK

2010

[Polycystic ovary syndrome and comorbidity].

20089454

Nasr A

2010

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study.

20089616

Chazenbalk G

2010

Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.

20091537

Tang T

2010

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

20092453

Wierman ME

2010

Endocrine aspects of women's sexual function.

20092643

Tan S

2010

Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

20093087

Kumbak B

2010

Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist.

20093088

Dowling-Lacey D

2010

Two singleton live births after the transfer of cryopreserved-thawed day-3 embryos following an unstimulated in-vitro oocyte maturation cycle.

20093255

Chen MJ

2010

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.

20094848

Zhuo G

2010

A 9-bp deletion homoplasmy in women with polycystic ovary syndrome revealed by mitochondrial genome-mutation screen.

20096821

Palomba S

2010

Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.

20096827

Dewailly D

2010

Polycystic ovary syndrome (PCOS).

20096985

Panidis D

2010

Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome.

20097337

Luque-Ram?rez M

2010

The determinants of insulin sensitivity, ?-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.

20097466

Strowitzki T

2010

The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients.

20098444

Nader S

2010

Reproductive endocrinology: live birth prediction in polycystic ovary syndrome.

20100610

Marsillach J

2010

Paraoxonase-1 in female infertility: a possible role against oxidative stress-induced inflammation.

20103703

Nikolajuk A

2010

Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.

20104424

Young SL

2010

Progesterone function in human endometrium: clinical perspectives.

20104428

Aghajanova L

2010

Altered gene expression profiling in endometrium: evidence for progesterone resistance.

20106839

Palomba S

2010

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.

20108521

Fica S

2008

Insulin resistance and fertility in polycystic ovary syndrome.

20110635

Caputo V

2010

Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.

20110726

Moran C

2010

Prevalence of polycystic ovary syndrome and related disorders in mexican women.

20111659

Alexander CJ

2009

Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.

20113146

Zhao JZ

2010

Effects of oral contraceptives and metformin on the outcome of in vitro maturation in infertile women with polycystic ovary syndrome.

20117778

Deeks AA

2010

Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation.

20120899

Yoshihara K

2009

Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome.

20121503

Chhabra S

2010

Menstrual dysfunction in rural young women and the presence of polycystic ovarian syndrome.

20121657

Vlaisavljevi? V

2010

An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.

20125012

Mintzer S

2010

Metabolic consequences of antiepileptic drugs.

20129994

Pandey S

2010

Should access to fertility treatment be determined by female body mass index?

20130411

Chae SJ

2010

Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.

20137672

Lin JF

2009

[Consensus, controversies and evidence-based research in future of polycystic ovary syndrome].

20137674

Wang Y

2009

[Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].

20137675

Xu XH

2009

[Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria].

20137676

Li X

2009

[Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].

20138007

Celik O

2010

Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS.

20138267

Kaya C

2010

Serum antim?llerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction.

20141388

Glintborg D

2010

An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome.

20143080

Mallappa Saroja CS

2010

Polycystic ovaries: review of medical information on the internet for patients.

20146169

Kaya C

2010

Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.

20146658

Li G

2010

Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome.

20147730

Ortega HH

2010

Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.

20148738

Arikan S

2010

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.

20148739

Fux Otta C

2010

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.

20149393

Roepke S

2010

Incidence of polycystic ovaries and androgen serum levels in women with borderline personality disorder.

20150576

Park AS

2010

Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism.

20153853

Hart R

2010

Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antim?llerian hormone in adolescence: a prospective cohort study.

20153855

Berdahl DM

2010

Detection of enlarged yolk sac on early ultrasound is associated with adverse pregnancy outcomes.

20156067

Baillargeon JP

2010

Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.

20156703

Peitsidis P

2010

Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review.

20159001

Yildiz BO

2010

Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS.

20159883

Moran LJ

2010

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

20170341

Karabulut A

2010

Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome.